Avadel Pharmaceuticals (AVDL) Research & Development: 2009-2021
Historic Research & Development for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Dec 2021 value amounting to $2.1 million.
- Avadel Pharmaceuticals' Research & Development fell 60.08% to $2.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $17.1 million, marking a year-over-year decrease of 16.33%. This contributed to the annual value of $17.1 million for FY2021, which is 16.33% down from last year.
- According to the latest figures from Q4 2021, Avadel Pharmaceuticals' Research & Development is $2.1 million, which was down 51.83% from $4.4 million recorded in Q3 2021.
- In the past 5 years, Avadel Pharmaceuticals' Research & Development ranged from a high of $11.9 million in Q2 2018 and a low of $2.1 million during Q4 2021.
- Its 3-year average for Research & Development is $5.9 million, with a median of $5.5 million in 2020.
- In the last 5 years, Avadel Pharmaceuticals' Research & Development skyrocketed by 75.06% in 2018 and then tumbled by 60.58% in 2020.
- Avadel Pharmaceuticals' Research & Development (Quarterly) stood at $11.3 million in 2017, then crashed by 46.26% to $6.1 million in 2018, then climbed by 27.46% to $7.8 million in 2019, then slumped by 31.86% to $5.3 million in 2020, then tumbled by 60.08% to $2.1 million in 2021.
- Its last three reported values are $2.1 million in Q4 2021, $4.4 million for Q3 2021, and $6.8 million during Q2 2021.